Tamarly Intelligence
Company · MRK (NYSE)

Merck

Pharmaceutical Preparations

Key figures
Revenue, 2025
$65.01B
Employees
0
Industry
Pharmaceutical Preparations (SIC 2834)
Institutional holders
3,824 at 30 Jun 2026 (3,796 the quarter before)
SEC number
310158
LEI
96760004Q9TBK1DS6T62

Source: SEC EDGAR filings and company facts, SEC Form 13F; checked 26 Oct 2026

Latest filings
13 Oct 2026
8-K 8-K
7 Aug 2026
13F-HR 13F-HR
7 Aug 2026
10-Q 10-Q
4 Aug 2026
8-K FORM 8-K
28 May 2026
8-K FORM 8-K

Source: SEC EDGAR

With a free account

A free account opens 10 full pages a month and lets you follow this page: 12 quarters of figures, every filing and document, earnings call transcripts, holders and ownership changes, the Brain's cards and graph, exports to Excel.

Start freeSign in

Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.

Merck: Revenue $65.01B (2025), filings, holders and country risk | Tamarly